Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm
Seeking Alpha
Friday, June 27, 2014 - 9:47am
tags:
MannKind, Afrezza, diabetes, FDA
Bayer's Stivarga endorsed for gastrointestinal stromal tumors
Yahoo/Reuters
Friday, June 27, 2014 - 9:43am
tags:
Bayer, Stivarga, gastrointestinal stromal tumors, Europe
Novo Nordisk's Diabetes Pill Shows Promise
Seeking Alpha
Friday, June 27, 2014 - 9:37am
tags:
diabetes, Novo Nordisk, Merrion, Emisphere, semaglutide, NN9924
First Robotic Legs Cleared by U.S. to Help Paralyzed Walk
Bloomberg
Friday, June 27, 2014 - 9:28am
tags:
robotic legs, devices, Argo Medical Technologies, FDA, ReWalk
Ranbaxy gets FDA approval for Novartis's Diovan generic
Yahoo/Reuters
Friday, June 27, 2014 - 9:25am
tags:
FDA, Novartis, Ranbaxy, Diovan, generics, India
2 Biotechs Race To Treat Movement Disorders
Seeking Alpha
Friday, June 27, 2014 - 9:23am
tags:
movement disorders, tetrabenazine, Auspex Pharmaceuticals, Neurocrine Biosciences, tardive dyskinesia, chorea
Lilly Wins EU Backing for Generic of Sanofi’s Lantus
Bloomberg
Friday, June 27, 2014 - 9:19am
tags:
Europe, generics, Eli Lilly, Sanofi, Lantus, diabetes
GW Pharmaceuticals Closes U.S. Public Offering; Cannabis-Based Medicines Progress
Forbes
Friday, June 27, 2014 - 9:17am
tags:
GW Pharma, Medical Marijuana, FDA
U.S. Senators Seek Review for Hostile Bid on Allergan
Bloomberg
Thursday, June 26, 2014 - 12:49pm
tags:
Allergan, hostile bid, Valeant Pharmaceuticals, M&A
Biogen Idec Has Lagged Its Biotech Peers, Now Is The Time To Shine!
Seeking Alpha
Thursday, June 26, 2014 - 12:48pm
tags:
Biogen Idec
Polaris preps for a $400M fund to back a new wave of biotechs
Fierce Biotech
Thursday, June 26, 2014 - 10:57am
tags:
Polaris Partners, biotech, venture funds
Closer Look at Gilead's Slowing Hep C Prescriptions
TheStreet.com
Thursday, June 26, 2014 - 10:55am
tags:
Gilead, hepatitis C, Sovaldi
Sequenom: A Reversal Of Misfortune
Seeking Alpha
Thursday, June 26, 2014 - 10:24am
tags:
Sequenom, diagnostics, Verinata
Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land
Fierce Pharma Marketing
Thursday, June 26, 2014 - 10:21am
tags:
drug launches, Tecfidera, Sovaldi, Aubagio, Imbruvica, Tivicay, Breo Ellipta and Anoro Ellipta, Kadcyla, Invokana, Pomolyst
Biotech Stocks to Watch Today: Agenus, Allergan and Auxilium Pharmaceuticals
Motley Fool
Thursday, June 26, 2014 - 10:15am
tags:
Agenus, Allergan, Auxilium, M&A, QLT, Valeant Pharmaceuticals, vaccines, herpes simplex 2
Coronado reports results from pilot study of TSO in adults with autism
The Fly on the Wall
Thursday, June 26, 2014 - 10:09am
tags:
Coronado Biosciences, TSO, autism
An Early Valuation Of Neuralstem's NSI-189 For MDD
Seeking Alpha
Thursday, June 26, 2014 - 10:08am
tags:
Neuralstem, NSI-189, major depressive disorder
Gilead Will Continue Its Rise
Seeking Alpha
Thursday, June 26, 2014 - 10:07am
tags:
Gilead Sciences, Sovaldi, hepatitis C
For Intuitive Surgical's New Robot, The World Just Got a Whole Lot Bigger
Motley Fool
Thursday, June 26, 2014 - 9:54am
tags:
Intuitive Surgical, robot-assisted surgery, devices, Da Vinci Surgical System, Europe
Auxilium Pharma to buy Canadian eye drug maker QLT
Yahoo/Reuters
Thursday, June 26, 2014 - 9:41am
tags:
Auxilium, M&A, Canada, QLT

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.